Knowledge at the heart of leadership
Welcome to Liftstream - Life Sciences Executive Search and Leadership Advisory

Cubist augments position in antibiotic market with Trius and Optimer buys

Authored by Paul Foster

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Inhalable gene therapy may aid PAH patients

Authored by James Sheppard

Read the full article…

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , , , | Leave a comment

Isis gains milestone from GSK for rare disease trial and Aegerion takes them on in HoFH

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Liftstream invites Guest Bloggers

Liftstream would like to invite guest bloggers to contribute to our blog and newsletter on www.liftstream.com/blog. Liftstream invites articles on any area within the life science field. In particular, Liftstream would be interest in hearing the thoughts and opinions of people working in areas of the life sciences market with a focus towards transformational innovation, such as rare diseases, medical device, companion diagnostics and regenerative medicine.

Read the full article…

Posted in General, Job Hunting Advice, M&A Finance and Funding, Medical Device, Orphan Drugs and Rare Diseases, Pharmaceutical business, Recruitment Market, Workplace Diversity | Leave a comment

‘Large company man’…a role in start-ups?

Authored by Karl Simpson

Read the full article…

Posted in Recruitment Market | Tagged , , , , , , , , , , , , , , | Leave a comment

Topotarget given Orphan designation for rare cancer therapy

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases | Tagged , , , , , , , , , , , , | Leave a comment

Prosensa, Sarepta, PTC, Summit and DART all contribute to the ubiquity of news in Duchenne

Authored by James Sheppard

Read the full article…

Posted in M&A Finance and Funding, Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments

PAH franchise and cost cutting prevent Actelion from listing further

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , | Leave a comment

EMA’s COMP appoints team to assess orphan application in dengue fever

Authored by Karl Simpson

Read the full article…

Posted in Orphan Drugs and Rare Diseases, Pharmaceutical business | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment

Esophageal cancer: Merrimack’s bispecific MM-111 moves to phase 2 and new HPV research

Authored by Karl Simpson

Read the full article…

Posted in Pharmaceutical business | Tagged , , , , , , , , , , , , , , , | Leave a comment




Contact Us

   Liftstream Ltd.
67 Grosvenor Street
London
W1K 3JN

   Tel: ​+44 (0)20 3178 5864
   info@liftstream.com

Register your CV

Apply for sector specific vacancies or request a confidential discussion



Registered in England No: 5009233
VAT: 843679292

Follow Us





Sitemap